Molecular characterization of a H5N1 highly pathogenic avian influenza virus clade 2.3.2.1b circulating in vietnam in 2011

Veterinary Microbiology

Volumn 165, Issue 3-4, 2013, Pages 341-348

  Tung, Dau Huy ^a   Van Quyen, Dong ^a   Nguyen, Tung ^b   Xuan, Hanh Tran ^c   Nam, Thang Nguyen ^d   Duy, Khang Dinh ^a  

^a INSTITUTE OF BIOTECHNOLOGY   (Viet Nam)

^b National Center for Veterinary Diagnostics   (Viet Nam)

^c NAVETCO Veterinary Medicine Company   (Viet Nam)

^d Thai Binh University of Medicine   (Viet Nam)

Author keywords

Challenge; Genetic characterization; H5N1; NIBRG 14

Indexed keywords

AVIAN INFLUENZA VACCINE; HEMAGGLUTININ; NIGRG 14 VACCINE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CHICKEN; CONTROLLED STUDY; DUCK; HOST CELL; INFLUENZA VIRUS A H5N1; MOLECULAR CLONING; MORTALITY; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SINGLE DRUG DOSE; VACCINATION; VIET NAM; VIROGENESIS; VIRUS CHARACTERIZATION; VIRUS GENE; VIRUS MUTATION; VIRUS REPLICATION; VIRUS SHEDDING; VIRUS STRAIN; VIRUS VIRULENCE; WEAKNESS;

AVES; AVIAN INFLUENZA VIRUS; CERCOPITHECINE HERPESVIRUS 1;

ANIMALS; CROSS PROTECTION; DUCKS; HEMAGGLUTININS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; MUTATION; PHYLOGENY; REAL-TIME POLYMERASE CHAIN REACTION; VACCINATION; VIETNAM; VIRULENCE; VIRUS SHEDDING;

EID: 84893012934     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2013.04.021     Document Type: Article

References (38)

1. Alexander D.J. A review of avian influenza in different bird species. Vet. Microbiol. 2000, 74:3-13.
2. Alexander D.J., Parsons G., Manvell R.J. Experimental assessment of the pathogenicity of eight avian influenza A viruses of H5 subtype for chickens, turkeys, ducks and quail. Avian. Pathol. 1986, 15:647-662.
3. Allan W.H., Lancaster J.E., Toth B. Newcastle disease vaccines, their production and use. FAO Animal Production Health, Series-10 1978, United Nations, Rome, pp. 57-62.
4. Amonsin A., Lapkuntod J., Suwannakarn K., Kitikoon P., Suradhat S., Tantilertcharoen R., Boonyapisitsopa S., Bunpapong N., Wongphatcharachai M., Wisedchanwet T., Theamboonlers A., Poovorawan Y., Sasipreeyajan J., Thanawongnuwech R. Genetic characterization of 2008 reassortant influenza A virus (H5N1), Thailand. Virol. J. 2010, 7:233.
5. Cattoli G., Milani A., Temperton N., Zecchin B., Buratin A., Molesti E., Aly M.M., Arafa A., Capua I. Antigenic drift in H5N1 avian influenza virus in poultry is driven by mutations in major antigenic sites of the hemagglutinin molecule analogous to those for human influenza virus. J. Virol. 2011, 85:8718-8724.
6. Claas E.C., Osterhaus A.D., van Beek R., De Jong J.C., Rimmelzwaan G.F., Senne D.A., Krauss S., Shortridge K.F., Webster R.G. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 1998, 351:472-477.
7. DiNapoli J.M., Yang L., Suguitan A., Elankumaran S., Dorward D.W., Murphy B.R., Samal S.K., Collins P.L., Bukreyev A. Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus. J. Virol. 2007, 81:11560-11568.
8. Dung N.T., Vinh N.T., Vijaykrishna D., Webster R.G., Guan Y., Malik Peiris J.S., Smith G.J. Multiple sublineages of influenza A virus (H5N1), Vietnam, 2005-2007. Emerg. Infect. Dis. 2008, 14:632-636.
9. FAO, 2008. New Avian Influenza Flare-ups. http://www.fao.org/newsroom/en/news/2008/1000775/index.html.
10. Guan Y., Smith G.J., Webby R., Webster R.G. Molecular epidemiology of H5N1 avian influenza. Rev. Sci. Tech. 2009, 28:39-47.
11. Hobson D., Curry R.L., Beare A.S., Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J. Hyg. (Lond.) 1972, 70:767-777.
12. Hoffmann E., Stech J., Guan Y., Webster R.G., Perez D.R. Universal primer set for the full-length amplification of all influenza A viruses. Arch. Virol. 2001, 146:2275-2289.
13. Ito T., Goto H., Yamamoto E., Tanaka H., Takeuchi M., Kuwayama M., Kawaoka Y., Otsuki K. Generation of a highly pathogenic avian influenza A virus from an avirulent field isolate by passaging in chickens. J. Virol. 2001, 75:4439-4443.
14. Kishida N., Sakoda Y., Isoda N., Matsuda K., Eto M., Sunaga Y., Umemura T., Kida H. Pathogenicity of H5 influenza viruses for ducks. Arch. Virol. 2005, 150:1383-1392.
15. Klenk H.D., Garten W., Matrosovich M. Molecular mechanisms of interspecies transmission and pathogenicity of influenza viruses, lessons from the 2009 pandemic. Bioessays 2011, 33:180-188.
16. Le, M.T., Wertheim, H.F., Nguyen, H.D., Taylor, W., Hoang, P.V., Vuong, C.D., Nguyen, H.L., Nguyen, H.H., Nguyen, T.Q., Nguyen, T.V., Van, T.D., Ngoc, B.T., Bui, T.N., Nguyen, B.G., Nguyen, L.T., Luong, S.T., Phan, P.H., Pham, H.V., Nguyen, T., Fox, A., Nguyen, C.V., Do, H.Q., Crusat, M., Farrar, J., Nguyen, H.T., de Jong, M.D., Horby, P., 2008. Influenza A H5N1 clade 2.3.4 virus with a different antiviral susceptibility profile replaced clade 1 virus in humans in northern Vietnam. PLoS ONE 3, e3339.
17. Le T., Doan T.H., Quyen D., Le K.X., Pham V., Nagataki M., Nomura H., Ikeue Y., Watanabe Y., Agatsuma T. The adjuvant effect of Sophy beta-glucan to the antibody response in poultry immunized by the avian influenza A H5N1 and H5N2 vaccines. J. Microbiol. Biotechnol. 2011, 21:405-411.
18. Lvov D.K., Shchelkanov M.Y., Prilipov A.G., Vlasov N.A., Fedyakina I.T., Deryabin P.G., Alkhovsky S.V., Grebennikova T.V., Zaberezhny A.D., Suarez D.L. Evolution of highly pathogenic avian influenza H5N1 virus in natural ecosystems of northern Eurasia (2005-08). Avian Dis. 2010, 54:483-495.
19. Matrosovich M., Zhou N., Kawaoka Y., Webster R. The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties. J. Virol. 1999, 73:1146-1155.
20. Melidou A., Gioula G., Exindari M., Chatzidimitriou D., Diza-Mataftsi E. Influenza A(H5N1): an overview of the current situation. Euro Surveill. 2009, 14.
21. Monne I., Ormelli S., Salviato A., De Battisti C., Bettini F., Salomoni A., Drago A., Zecchin B., Capua I., Cattoli G. Development and validation of a one-step real-time PCR assay for simultaneous detection of subtype H5, H7, and H9 avian influenza viruses. J. Clin. Microbiol. 2008, 46:1769-1773.
22. Moro de Sousa R.L., Montassier H.J., Pinto A.A. Detection and quantification of antibodies to Newcastle disease virus in ostrich and rhea sera using a liquid phase blocking enzyme-linked immunosorbent assay. Clin. Diagn. Lab. Immunol. 2000, 7:940-944.
23. Nguyen T., Davis C.T., Stembridge W., Shu B., Balish A., Inui K., Do H.T., Ngo H.T., Wan X.F., McCarron M., Lindstrom S.E., Cox N.J., Nguyen C.V., Klimov A.I., Donis R.O. Characterization of a highly pathogenic avian influenza H5N1 virus sublineage in poultry seized at ports of entry into Vietnam. Virology 2009, 387:250-256.
24. Ninomiya A., Imai M., Tashiro M., Odagiri T. Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse model. Vaccine 2007, 25:3554-3560.
25. Peyre M., Fusheng G., Desvaux S., Roger F. Avian influenza vaccines: a practical review in relation to their application in the field with a focus on the Asian experience. Epidemiol. Infect. 2009, 137:1-21.
26. Pfeiffer J., Pantin-Jackwood M., To T.L., Nguyen T., Suarez D.L. Phylogenetic and biological characterization of highly pathogenic H5N1 avian influenza viruses (Vietnam 2005) in chickens and ducks. Virus. Res. 2009, 142:108-120.
27. Stevens J., Blixt O., Tumpey T.M., Taubenberger J.K., Paulson J.C., Wilson I.A. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 2006, 312:404-410.
28. Sun S., Wang Q., Zhao F., Chen W., Li Z. Glycosylation site alteration in the evolution of influenza A (H1N1) viruses. PLoS ONE 2011, 6:e22844.
29. Swayne D.E. Principles for vaccine protection in chickens and domestic waterfowl against avian influenza: emphasis on Asian H5N1 high pathogenicity avian influenza. Ann. N. Y. Acad. Sci. 2006, 1081:174-181.
30. Wan X.F., Nguyen T., Davis C.T., Smith C.B., Zhao Z.M., Carrel M., Inui K., Do H.T., Mai D.T., Jadhao S., Balish A., Shu B., Luo F., Emch M., Matsuoka Y., Lindstrom S.E., Cox N.J., Nguyen C.V., Klimov A., Donis R.O. Evolution of highly pathogenic H5N1 avian influenza viruses in Vietnam between 2001 and 2007. PLoS ONE 2008, 3:e3462.
31. Wang W., Lu B., Zhou H., Suguitan A.L., Cheng X., Subbarao K., Kemble G., Jin H. Glycosylation at 158N of the hemagglutinin protein and receptor binding specificity synergistically affect the antigenicity and immunogenicity of a live attenuated H5N1 A/Vietnam/1203/2004 vaccine virus in ferrets. J. Virol. 2010, 84:6570-6577.
32. Webster R., Cox N., Stohr K. WHO Manual on Animal Influenza Diagnosis and Surveillance 2002, World Health Organization, Geneva, Switzerland.
33. WHO, 2002. Manual on Animal Influenza Diagnosis and Surveillance http://www.wpro.who.int/entity/emerging_diseases/documents/manual_on_animal_ai_diagnosis_and_surveillance/en/index.html.
34. WHO, 2011. Avian Influenza http://www.who.int/mediacentre/factsheets/avian_influenza/en/index.html.
35. WHO 2011. FAO-OIE-WHO Technical Update: Current Evolution of Avian Influenza H5N1 Viruses - 7 September 2011 http://www.who.int/influenza/human_animal_interface/en/.
36. WHO, 2012. Cumulative Number of Confirmed Human Cases of Avian Influenza A(H5N1) Reported to WHO http://www.who.int/influenza/human_animal_interface/H5N1_cumulative_table_archives/en/index.html.
37. WHO, 2012. Influenza Vaccine Viruses and Reagents http://www.who.int/influenza/vaccines/virus/en/.
38. Yang Y., Halloran M.E., Sugimoto J.D., Longini I.M. Detecting human-to-human transmission of avian influenza A (H5N1). Emerg. Infect. Dis. 2007, 13:1348-1353.